Preliminary data from our laboratory (PI, Dr. Ricny) showed that tau Ab from the serum of AD patients interact equally with both, recombinant and natural monomeric tau derived from brain homogenates 97. The gene discussed is MAPT; the disease is Alzheimer disease.